Nigel Sacks

1.6k total citations
37 papers, 1.2k citations indexed

About

Nigel Sacks is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, Nigel Sacks has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cancer Research, 17 papers in Oncology and 16 papers in Genetics. Recurrent topics in Nigel Sacks's work include Breast Cancer Treatment Studies (17 papers), Estrogen and related hormone effects (12 papers) and Breast Lesions and Carcinomas (9 papers). Nigel Sacks is often cited by papers focused on Breast Cancer Treatment Studies (17 papers), Estrogen and related hormone effects (12 papers) and Breast Lesions and Carcinomas (9 papers). Nigel Sacks collaborates with scholars based in United Kingdom, Australia and Canada. Nigel Sacks's co-authors include Mitch Dowsett, Michael Baum, Janine Salter, Roger A’Hern, Ian E. Smith, Michael B. Sporn, Ian C. P. Smith, KA MacLennan, K C Flanders and A McKinna and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

Nigel Sacks

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nigel Sacks United Kingdom 18 590 521 466 369 268 37 1.2k
Katherine DeSchryver United States 15 441 0.7× 441 0.8× 218 0.5× 194 0.5× 234 0.9× 29 1.1k
Atsuo Tsuchiya Japan 17 421 0.7× 658 1.3× 191 0.4× 595 1.6× 397 1.5× 96 1.4k
Anne Irene Hagen Norway 16 411 0.7× 564 1.1× 608 1.3× 179 0.5× 178 0.7× 31 1.2k
Alfred A. Fracchia United States 16 719 1.2× 548 1.1× 436 0.9× 511 1.4× 202 0.8× 25 1.4k
Soo Youn Bae South Korea 24 824 1.4× 789 1.5× 188 0.4× 487 1.3× 328 1.2× 92 1.7k
J Askergren Sweden 15 530 0.9× 492 0.9× 705 1.5× 273 0.7× 133 0.5× 26 1.4k
Audrey Barlock United States 12 380 0.6× 487 0.9× 451 1.0× 166 0.4× 207 0.8× 13 1.0k
S Kumaoka Japan 13 602 1.0× 1.1k 2.1× 553 1.2× 195 0.5× 291 1.1× 33 1.9k
Lars Ottestad Norway 15 517 0.9× 1.2k 2.4× 583 1.3× 170 0.5× 488 1.8× 35 1.7k
T. Tominaga Japan 18 720 1.2× 825 1.6× 459 1.0× 107 0.3× 730 2.7× 82 1.7k

Countries citing papers authored by Nigel Sacks

Since Specialization
Citations

This map shows the geographic impact of Nigel Sacks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel Sacks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel Sacks more than expected).

Fields of papers citing papers by Nigel Sacks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel Sacks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel Sacks. The network helps show where Nigel Sacks may publish in the future.

Co-authorship network of co-authors of Nigel Sacks

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel Sacks. A scholar is included among the top collaborators of Nigel Sacks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel Sacks. Nigel Sacks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marsden, Jo & Nigel Sacks. (2004). The Role of Hormone Replacement Therapy and Alternative Treatments. 3(2). 67–78. 1 indexed citations
2.
Davies, Giles, Janine Salter, Margaret Hills, et al.. (2003). Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer.. PubMed. 9(7). 2651–6. 111 indexed citations
3.
Marsden, Jo & Nigel Sacks. (2002). The national randomised trial of hormone replacement therapy in women with a history of early stage breast cancer: an update. The Journal of the British Menopause Society. 8(4). 129–129. 7 indexed citations
4.
Harper‐Wynne, Catherine, Gillian Ross, Nigel Sacks, et al.. (2002). Effects of the Aromatase Inhibitor Letrozole on Normal Breast Epithelial Cell Proliferation and Metabolic Indices in Postmenopausal Women. Cancer Epidemiology and Prevention Biomarkers. 11(7). 614–621. 5 indexed citations
5.
Harper‐Wynne, Catherine, Gillian Ross, Nigel Sacks, et al.. (2002). Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention.. PubMed. 11(7). 614–21. 120 indexed citations
6.
Tan, Su-Ming, Kasim A. Behranwala, P. A. Trott, et al.. (2002). A retrospective study comparing the individual modalities of triple assessment in the pre-operative diagnosis of invasive lobular breast carcinoma. European Journal of Surgical Oncology. 28(3). 203–208. 24 indexed citations
7.
Marsden, Jo, Michael Baum, Roger A’Hern, et al.. (2001). The impact of hormone replacement therapy on breast cancer patients' quality of life and sexuality: a pilot study. The Journal of the British Menopause Society. 7(2). 85–91. 6 indexed citations
8.
Boer, Richard H. De, W H Allum, S. Ebbs, et al.. (2000). Multimodality therapy in inflammatory breast cancer: Is there a place for surgery?. Annals of Oncology. 11(9). 1147–1154. 34 indexed citations
9.
Spillane, Andrew J. & Nigel Sacks. (2000). ROLE OF AXILLARY SURGERY IN EARLY BREAST CANCER: REVIEW OF THE CURRENT EVIDENCE. Australian and New Zealand Journal of Surgery. 70(7). 515–524. 19 indexed citations
10.
Marsden, Jo, Malcolm Whitehead, Roger A’Hern, M Baum, & Nigel Sacks. (2000). Are randomized trials of hormone replacement therapy in symptomatic women with breast cancer feasible?. Fertility and Sterility. 73(2). 292–299. 55 indexed citations
11.
Sutton, Richard, et al.. (1999). Is mastectomy overtreatment for Paget's disease of the nipple?. The Breast. 8(4). 191–194. 11 indexed citations
12.
Baum, M, et al.. (1998). Hormone Replacement Therapy in Women with Previous Breast Cancer. Trends in Endocrinology and Metabolism. 9(1). 32–38. 7 indexed citations
13.
Brown, Ann L., et al.. (1998). Primary osteosarcoma of the breast: Imaging and histological features. Clinical Radiology. 53(12). 920–922. 14 indexed citations
14.
15.
Marsden, Jo & Nigel Sacks. (1996). Hormone replacement therapy and breast cancer. Endocrine Related Cancer. 3(2). 81–97. 11 indexed citations
16.
Mokbel, Kefah, Mansoor M. Ahmed, Anthony Nash, & Nigel Sacks. (1995). Reexcision operations in nonpalpable breast cancer. Journal of Surgical Oncology. 58(4). 225–228. 39 indexed citations
17.
Allan, Stuart M., Christopher Dean, S. A. Eccles, & Nigel Sacks. (1994). Clinical radioimmunolocalization with a rat monoclonal antibody directed against c-erbB-2. Cell Biophysics. 24-25(1-3). 93–98. 12 indexed citations
18.
MacLennan, KA, K C Flanders, Nigel Sacks, et al.. (1992). Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment.. PubMed. 52(15). 4261–4. 285 indexed citations
19.
Sacks, Nigel, et al.. (1992). Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer.. PubMed. 18(2). 98–102. 13 indexed citations
20.
Stacker, Steven A., Christopher H. Thompson, Nigel Sacks, et al.. (1988). Detection of mammary serum antigen in sera from breast cancer patients using monoclonal antibody 3E1.2.. PubMed. 48(24 Pt 1). 7060–6. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine DeSchryver Breakdown of academic impact, for papers by Atsuo Tsuchiya Breakdown of academic impact, for papers by Anne Irene Hagen Breakdown of academic impact, for papers by Alfred A. Fracchia Breakdown of academic impact, for papers by Soo Youn Bae Breakdown of academic impact, for papers by J Askergren Breakdown of academic impact, for papers by Audrey Barlock Breakdown of academic impact, for papers by S Kumaoka Breakdown of academic impact, for papers by Lars Ottestad Breakdown of academic impact, for papers by T. Tominaga
Rankless by CCL
2026